News
Vinay Prasad, a top regulator at the US Food and Drug Administration, has left the agency after a controversy over his ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Hosted on MSN15h
WSJ Opinion: A Shakeup at the FDA
Journal Editorial Report: Vinay Prasad exits after gene-therapy reversal. Why Britain faces a bigger Trump tariff blow ...
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results